| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 12/10/2009 | US20090306048 Pharmaceutical use of substituted piperidine carboxamides |
| 12/10/2009 | US20090306024 Combination preparations of o-acetylsalicylic acid salts |
| 12/10/2009 | US20090306015 Pharmaceutical compositions and methods of use of highly lipophilic sulfhydryl compounds |
| 12/10/2009 | US20090306001 Novel amphiphilic derivatives of alpha-c-phenyl-n-tert-butylnitrone |
| 12/10/2009 | US20090305999 Utilization of hypertension/hypercardia-preventing effect of d-allose |
| 12/10/2009 | US20090305994 Compounds Modulating Vegf Receptor and Uses Thereof |
| 12/10/2009 | US20090305991 33 Human Secreted Proteins |
| 12/10/2009 | US20090305990 Bi-lateral local renal delivery for treating congestive heart failure and for bnp therapy |
| 12/10/2009 | US20090305951 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival cells |
| 12/10/2009 | US20090305365 Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof |
| 12/10/2009 | US20090305289 Screening method to identify protective substances for the treatment of neurodegenerative and/or ischaemic diseases |
| 12/10/2009 | US20090304819 Systemic Treatment of Pathological Conditions Resulting from Oxidative Stress and/or Redox Imbalance |
| 12/10/2009 | US20090304818 Method of treatment |
| 12/10/2009 | US20090304797 Process for the Preparation of Micronized Valsartan |
| 12/10/2009 | US20090304781 Master gene of arteriogenesis |
| 12/10/2009 | US20090304769 Methods for identifying agents and their use for the prevention of restenosis |
| 12/10/2009 | US20090304765 R-ras activity in vascular regulation |
| 12/10/2009 | US20090304755 Pharmaceutical formulation of losartan |
| 12/10/2009 | US20090304671 Method of treating endothelial dysfunction |
| 12/10/2009 | US20090304654 Methods for isolating adipose-derived stem cells and therapeutic use thereof |
| 12/10/2009 | US20090304625 Modulators of cardiac cell hypertrophy and hyperplasia |
| 12/10/2009 | US20090304583 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 12/10/2009 | CA2727085A1 Chimeric natriuretic polypeptides and methods for inhibiting cardiac remodeling |
| 12/10/2009 | CA2727018A1 Anthraquinones and analogs from rhuem palmatum for treatment of estrogen receptor beta-mediated conditions |
| 12/10/2009 | CA2726903A1 Long-acting glp-1 derivatives, and methods of treating cardiac dysfunction |
| 12/10/2009 | CA2726885A1 Sirna of human osteopontin |
| 12/10/2009 | CA2726874A1 Novel treatments |
| 12/10/2009 | CA2726793A1 Pulsatile release of valsartan |
| 12/10/2009 | CA2726644A1 Pharmaceutical combination |
| 12/10/2009 | CA2726377A1 Aldosterone induced vascular elastin production |
| 12/10/2009 | CA2724320A1 Solid states of aliskiren free base |
| 12/09/2009 | EP2130920A2 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 12/09/2009 | EP2130829A1 Novel hydroxyindole derivative |
| 12/09/2009 | EP2130825A1 N-substituted thiomorpholine derivatives as the inhibitors of dipeptidyl peptidase iv and the pharmaceutical uses thereof |
| 12/09/2009 | EP2130552A1 Pharmaceutical composition comprising anti-grp78 antibody as active ingredient |
| 12/09/2009 | EP2130548A2 Growth Hormone Releasing Peptides |
| 12/09/2009 | EP2130546A1 Prophylactic agent for heart failure |
| 12/09/2009 | EP2130537A1 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 12/09/2009 | EP2130536A1 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 12/09/2009 | EP2129653A2 Novel p2y12 receptor antagonists |
| 12/09/2009 | EP2129403A2 Bispecific fusion protein having therapeutic and diagnostic potential |
| 12/09/2009 | EP2129382A1 Compositions and methods for tranquilizing heart muscle |
| 12/09/2009 | EP2129379A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors |
| 12/09/2009 | EP2129378A1 Therapeutic compositions |
| 12/09/2009 | EP1554256B1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 12/09/2009 | EP1518517B1 Drug-delivery endovascular stent |
| 12/09/2009 | EP1458754B1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 12/09/2009 | EP1252144B1 Substituted glutarimides and use thereof il-12 production inhibitors |
| 12/09/2009 | EP1129110B1 Platelet-derived growth factor d, dna coding therefor, and uses thereof |
| 12/09/2009 | CN101600712A Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibiting activity |
| 12/09/2009 | CN101600710A Substituted dipyridyl-dihydropyrazolones and use thereof |
| 12/09/2009 | CN101600708A Organic compounds |
| 12/09/2009 | CN101600474A 1,3-dihydroimidazoles for treating cardiovascular disorders |
| 12/09/2009 | CN101600446A Cellular preparations for use as a revascularisation stimulating agent |
| 12/09/2009 | CN101600437A Method of treatment |
| 12/09/2009 | CN101600432A Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same |
| 12/09/2009 | CN101597337A Conjugate of hydroxyalkyl starch and an active agent |
| 12/09/2009 | CN101597335A Recombined protein specially combined with fiber protein and application thereof |
| 12/09/2009 | CN101597324A Decapeptide inhibiting angiogenesis and use thereof |
| 12/09/2009 | CN101597262A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 12/09/2009 | CN101597261A Amorphous ivabradine hydrochloride |
| 12/09/2009 | CN101597231A NO donor medicine and synthesis method thereof |
| 12/09/2009 | CN101597212A Kirenol derivative and application thereof in preparation of proinflammatory cytokine inhibitor |
| 12/09/2009 | CN101596302A Medicine for treating coronary disease angina and preparation method thereof |
| 12/09/2009 | CN101596298A Traditional Chinese drop pills for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| 12/09/2009 | CN101596275A Quality control method for ginseng in Yixinshu Chinese medicinal preparation |
| 12/09/2009 | CN101596274A Quality control method for schisandra chinensis in Yixinshu Chinese medicinal preparation |
| 12/09/2009 | CN101596273A Quality control method for dwarf lilyturf turber in Yixinshu Chinese medicinal preparation |
| 12/09/2009 | CN101596241A Hemorrhoids fumigation medicine |
| 12/09/2009 | CN101596240A Shuangdan micro pill and preparation method thereof |
| 12/09/2009 | CN101596228A New use of pain-relieving plaster for injury and rheumatism |
| 12/09/2009 | CN101596226A Preparation method of epimedium total flavonoids |
| 12/09/2009 | CN101596222A Refined ginkgo biloba extract, powder and preparation method thereof |
| 12/09/2009 | CN101596221A Process for preparing water-soluble ginkgo biloba extract used for injection |
| 12/09/2009 | CN101596216A Microbiological preparation for preventing or treating diabetes and related symptoms |
| 12/09/2009 | CN101596203A Application of syringin in preparing drugs for treating cardiovascular and cerebrovascular diseases |
| 12/09/2009 | CN101596196A Ligustrazine and danshensu composition and pharmacology activity research |
| 12/09/2009 | CN101596195A Oral medicine composite for reducing blood pressure |
| 12/09/2009 | CN101596191A Method for treatment of disease using malonyl-coa decarboxylase inhibitor |
| 12/09/2009 | CN101596189A Medicinal composition containing imidazole-5-carboxylic derivative |
| 12/09/2009 | CN101596185A Application of formononetin in preparation of medicine capable of treating hypertension and ischemic angiocardiopathy and cerebrovascular disease |
| 12/09/2009 | CN101596184A Application of rosmarinic acid as peroxynitrite inhibitor |
| 12/09/2009 | CN101596182A Medicine composition containing salvianolic acid A, preparation method and application thereof as well as freeze-dried powder injection and water injection containing composition |
| 12/09/2009 | CN101596177A Coenzyme Q10 self-emulsifying composition, preparation method and application thereof |
| 12/09/2009 | CN101596161A Preparation method of sterile preparation of lipoalprostadil |
| 12/09/2009 | CN101596001A Natural egg for activating blood and nourishing the heart and preparation method thereof |
| 12/09/2009 | CN101595927A Natural tea for nourishing entrails and reducing blood fat, blood sugar and blood pressure and preparation method thereof |
| 12/09/2009 | CN101595925A Gastrodia tuber antihypertensive tea and preparation method thereof |
| 12/09/2009 | CN100567495C Methods for large scale production of recombinant DNA-derived tPA or K2S molecules |
| 12/09/2009 | CN100567483C FAD4, FAD5, FAD5-2 and FAD6 fatty acid desaturase enzyme family members and uses thereof |
| 12/09/2009 | CN100567301C Chlorophyll derivatives, preparation method and application thereof in medical agricultural chemicals |
| 12/09/2009 | CN100567278C Benzoyl guanidine derivative, preparation method and medical use thereof |
| 12/09/2009 | CN100567266C Cannabinoid receptor ligands |
| 12/09/2009 | CN100566734C Oral compositions for the treatment of cellulite |
| 12/09/2009 | CN100566732C Oral medicine fortreating piles |
| 12/09/2009 | CN100566730C Method of preparing tea for lowering blood pressure and lowering blood fat |
| 12/09/2009 | CN100566728C Method for extracting bitter buckwheat flavone in high purity |
| 12/09/2009 | CN100566720C Chinese medicine active ingredient composition for treating cardiovascular disease and use thereof |
| 12/09/2009 | CN100566710C New use of 6,7-dehydroroyleanone in pharmaceutical |
| 12/09/2009 | CN100566604C Nutritious health-care drink and its preparing method |